Aisling Capital Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $829K | Sell |
|
|||||
|
2023
Q2 | $762K | Hold |
|
|||||
|
2023
Q1 | $490K | Hold |
|
|||||
|
2022
Q4 | $761K | Hold |
|
|||||
|
2022
Q3 | $890K | Hold |
|
|||||
|
2022
Q2 | $854K | Hold |
|
|||||
|
2022
Q1 | $3.89M | Hold |
|
|||||
|
2021
Q4 | $8.03M | Hold |
|
|||||
|
2021
Q3 | $13.4M | Hold |
|
|||||
|
2021
Q2 | $11.8M | Hold |
|
|||||
|
2021
Q1 | $13.4M | Hold |
|
|||||
|
2020
Q4 | $13.3M | Hold |
|
|||||
|
2020
Q3 | $12M | Hold |
|
|||||
|
2020
Q2 | $15.6M | Buy |
|
|||||
|
2020
Q1 | $6.02M | Hold |
|
|||||
|
2019
Q4 | $9.86M | Hold |
|
|||||
|
2019
Q3 | $9.93M | Hold |
|
|||||
|
2019
Q2 | $8.84M | Buy |
|
|||||
|
2019
Q1 | $9.83M | Buy |
|
|||||
|
2018
Q4 | $6.51M | Buy |
|